Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Revue Francaise d'Allergologie is Scopus-indexed (Q4, CiteScore 0.4), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Elsevier Masson s.r.l..
Checked against the index lists dated .
ISSN 1877-0312Verify ISSN ↗1877-0320Verify ISSN ↗
Publisher: Elsevier Masson s.r.l.
Cost to publish: About US$1,880 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Immunology and Allergy | 222 / 234 | 5th | Q4 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2009–present, best quartile Q4, CiteScore 0.4.
Revue Francaise d'Allergologie is Q4 in Immunology and Allergy (rank 222 of 234), by CiteScore 2025.
Revue Francaise d'Allergologie is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 0.4, which places it in quartile Q4 at the 5th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.115, quartile Q4, with an H-index of 21.
The publisher lists an article processing charge of about US$1,880 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Revue Francaise d'Allergologie is published by Elsevier Masson s.r.l. Its print ISSN is 1877-0312 and its online ISSN is 1877-0320.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Revue Francaise d'Allergologie has an h-index of 18 and a 2-year mean of 0.09 citations per paper (OpenAlex). Its Scopus CiteScore is 0.4, quartile Q4. On 2-year citations it ranks #214 of 231 Scopus journals in Immunology and Allergy.
Revue Francaise d'Allergologie published 355 papers in 2025; its busiest recent year was 2023 with 399. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 83 research articles (2026), authors are most often from France (48.1%), Morocco (22.9%) and Türkiye (9.6%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 1 retracted paper is recorded (0.2 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.